nodes	percent_of_prediction	percent_of_DWPC	metapath
Vandetanib—ORM1—Tacrolimus—atopic dermatitis	0.133	0.35	CbGbCtD
Vandetanib—ALB—Tacrolimus—atopic dermatitis	0.0558	0.147	CbGbCtD
Vandetanib—ABCG2—Hydrocortisone—atopic dermatitis	0.033	0.0871	CbGbCtD
Vandetanib—CYP3A4—Pimecrolimus—atopic dermatitis	0.0294	0.0777	CbGbCtD
Vandetanib—FMO3—sweat—atopic dermatitis	0.0251	0.239	CbGeAlD
Vandetanib—ALB—Prednisone—atopic dermatitis	0.0226	0.0598	CbGbCtD
Vandetanib—ABCG2—Dexamethasone—atopic dermatitis	0.0205	0.0541	CbGbCtD
Vandetanib—CYP3A4—Tacrolimus—atopic dermatitis	0.0175	0.0462	CbGbCtD
Vandetanib—CYP3A4—Loratadine—atopic dermatitis	0.0128	0.0338	CbGbCtD
Vandetanib—CYP3A4—Methylprednisolone—atopic dermatitis	0.0117	0.0309	CbGbCtD
Vandetanib—PTK6—skin epidermis—atopic dermatitis	0.0114	0.108	CbGeAlD
Vandetanib—CYP3A4—Triamcinolone—atopic dermatitis	0.00888	0.0234	CbGbCtD
Vandetanib—CYP3A4—Betamethasone—atopic dermatitis	0.00761	0.0201	CbGbCtD
Vandetanib—CYP3A4—Prednisolone—atopic dermatitis	0.00751	0.0198	CbGbCtD
Vandetanib—CYP3A4—Hydrocortisone—atopic dermatitis	0.00712	0.0188	CbGbCtD
Vandetanib—CYP3A4—Prednisone—atopic dermatitis	0.0071	0.0187	CbGbCtD
Vandetanib—CYP3A4—Dexamethasone—atopic dermatitis	0.00443	0.0117	CbGbCtD
Vandetanib—PTK6—skin of body—atopic dermatitis	0.00352	0.0335	CbGeAlD
Vandetanib—RET—neck—atopic dermatitis	0.00287	0.0273	CbGeAlD
Vandetanib—TYRO3—skin of body—atopic dermatitis	0.00273	0.0259	CbGeAlD
Vandetanib—LTK—head—atopic dermatitis	0.0024	0.0228	CbGeAlD
Vandetanib—EPHA8—head—atopic dermatitis	0.0023	0.0218	CbGeAlD
Vandetanib—STK35—skin of body—atopic dermatitis	0.00227	0.0216	CbGeAlD
Vandetanib—KDR—neck—atopic dermatitis	0.00214	0.0203	CbGeAlD
Vandetanib—RIPK2—skin of body—atopic dermatitis	0.00209	0.0199	CbGeAlD
Vandetanib—ERBB3—skin of body—atopic dermatitis	0.002	0.019	CbGeAlD
Vandetanib—EPHA6—head—atopic dermatitis	0.00192	0.0182	CbGeAlD
Vandetanib—AXL—skin of body—atopic dermatitis	0.00185	0.0176	CbGeAlD
Vandetanib—PDGFRB—neck—atopic dermatitis	0.00185	0.0176	CbGeAlD
Vandetanib—TYRO3—head—atopic dermatitis	0.00178	0.0169	CbGeAlD
Vandetanib—EPHA5—head—atopic dermatitis	0.00178	0.0169	CbGeAlD
Vandetanib—LYN—head—atopic dermatitis	0.00177	0.0168	CbGeAlD
Vandetanib—BMPR1B—head—atopic dermatitis	0.00174	0.0165	CbGeAlD
Vandetanib—MAP3K19—head—atopic dermatitis	0.00174	0.0165	CbGeAlD
Vandetanib—FYN—skin of body—atopic dermatitis	0.00173	0.0164	CbGeAlD
Vandetanib—EPHB6—skin of body—atopic dermatitis	0.00162	0.0154	CbGeAlD
Vandetanib—SRC—skin of body—atopic dermatitis	0.0015	0.0143	CbGeAlD
Vandetanib—STK35—head—atopic dermatitis	0.00148	0.0141	CbGeAlD
Vandetanib—FLT4—head—atopic dermatitis	0.00137	0.013	CbGeAlD
Vandetanib—RIPK2—head—atopic dermatitis	0.00137	0.013	CbGeAlD
Vandetanib—FMO1—head—atopic dermatitis	0.00136	0.0129	CbGeAlD
Vandetanib—IRAK4—head—atopic dermatitis	0.00133	0.0127	CbGeAlD
Vandetanib—ERBB3—head—atopic dermatitis	0.00131	0.0124	CbGeAlD
Vandetanib—MKNK1—head—atopic dermatitis	0.00123	0.0117	CbGeAlD
Vandetanib—FGR—head—atopic dermatitis	0.00121	0.0115	CbGeAlD
Vandetanib—RET—head—atopic dermatitis	0.00121	0.0115	CbGeAlD
Vandetanib—AXL—head—atopic dermatitis	0.00121	0.0115	CbGeAlD
Vandetanib—PDGFRB—skin of body—atopic dermatitis	0.0012	0.0114	CbGeAlD
Vandetanib—FMO3—head—atopic dermatitis	0.00117	0.0111	CbGeAlD
Vandetanib—FYN—head—atopic dermatitis	0.00113	0.0107	CbGeAlD
Vandetanib—MAP4K5—head—atopic dermatitis	0.0011	0.0105	CbGeAlD
Vandetanib—TEK—head—atopic dermatitis	0.0011	0.0105	CbGeAlD
Vandetanib—ABL1—skin of body—atopic dermatitis	0.00107	0.0101	CbGeAlD
Vandetanib—EPHB6—head—atopic dermatitis	0.00106	0.01	CbGeAlD
Vandetanib—YES1—head—atopic dermatitis	0.00102	0.00969	CbGeAlD
Vandetanib—STK10—head—atopic dermatitis	0.00101	0.0096	CbGeAlD
Vandetanib—SRC—head—atopic dermatitis	0.000982	0.00932	CbGeAlD
Vandetanib—KDR—head—atopic dermatitis	0.000903	0.00857	CbGeAlD
Vandetanib—MAP2K5—head—atopic dermatitis	0.000903	0.00857	CbGeAlD
Vandetanib—PDGFRB—head—atopic dermatitis	0.000781	0.00742	CbGeAlD
Vandetanib—ABL1—head—atopic dermatitis	0.000697	0.00661	CbGeAlD
Vandetanib—VEGFA—Carbinoxamine—Diphenhydramine—atopic dermatitis	0.00064	0.12	CbGdCrCtD
Vandetanib—VEGFA—Dexamethasone—Desonide—atopic dermatitis	0.000438	0.0821	CbGdCrCtD
Vandetanib—VEGFA—Betamethasone—Desonide—atopic dermatitis	0.000438	0.0821	CbGdCrCtD
Vandetanib—VEGFA—Dexamethasone—Fluocinonide—atopic dermatitis	0.000351	0.0658	CbGdCrCtD
Vandetanib—VEGFA—Betamethasone—Fluocinonide—atopic dermatitis	0.000351	0.0658	CbGdCrCtD
Vandetanib—VEGFA—Dexamethasone—Fluocinolone Acetonide—atopic dermatitis	0.000341	0.0639	CbGdCrCtD
Vandetanib—VEGFA—Betamethasone—Fluocinolone Acetonide—atopic dermatitis	0.000341	0.0639	CbGdCrCtD
Vandetanib—VEGFA—Dexamethasone—Mometasone—atopic dermatitis	0.000272	0.051	CbGdCrCtD
Vandetanib—VEGFA—Betamethasone—Mometasone—atopic dermatitis	0.000272	0.051	CbGdCrCtD
Vandetanib—Vomiting—Fluocinolone Acetonide—atopic dermatitis	0.000188	0.000658	CcSEcCtD
Vandetanib—Alanine aminotransferase increased—Prednisone—atopic dermatitis	0.000187	0.000655	CcSEcCtD
Vandetanib—Haemoglobin—Triamcinolone—atopic dermatitis	0.000187	0.000653	CcSEcCtD
Vandetanib—Rash—Fluocinolone Acetonide—atopic dermatitis	0.000187	0.000652	CcSEcCtD
Vandetanib—Haemoglobin—Methylprednisolone—atopic dermatitis	0.000186	0.000652	CcSEcCtD
Vandetanib—Dermatitis—Fluocinolone Acetonide—atopic dermatitis	0.000186	0.000652	CcSEcCtD
Vandetanib—Haemorrhage—Triamcinolone—atopic dermatitis	0.000186	0.00065	CcSEcCtD
Vandetanib—Haemorrhage—Methylprednisolone—atopic dermatitis	0.000186	0.000649	CcSEcCtD
Vandetanib—Headache—Fluocinolone Acetonide—atopic dermatitis	0.000185	0.000648	CcSEcCtD
Vandetanib—Eye disorder—Hydrocortisone—atopic dermatitis	0.000185	0.000645	CcSEcCtD
Vandetanib—Gastrointestinal pain—Tacrolimus—atopic dermatitis	0.000184	0.000643	CcSEcCtD
Vandetanib—Conjunctivitis—Betamethasone—atopic dermatitis	0.000183	0.000639	CcSEcCtD
Vandetanib—Conjunctivitis—Dexamethasone—atopic dermatitis	0.000183	0.000639	CcSEcCtD
Vandetanib—Arrhythmia—Prednisolone—atopic dermatitis	0.000181	0.000632	CcSEcCtD
Vandetanib—Pancreatitis—Prednisone—atopic dermatitis	0.00018	0.000629	CcSEcCtD
Vandetanib—Vomiting—Mometasone—atopic dermatitis	0.00018	0.000628	CcSEcCtD
Vandetanib—Visual impairment—Methylprednisolone—atopic dermatitis	0.000179	0.000625	CcSEcCtD
Vandetanib—Rash—Mometasone—atopic dermatitis	0.000178	0.000623	CcSEcCtD
Vandetanib—Dermatitis—Mometasone—atopic dermatitis	0.000178	0.000622	CcSEcCtD
Vandetanib—Abdominal pain—Tacrolimus—atopic dermatitis	0.000178	0.000622	CcSEcCtD
Vandetanib—Body temperature increased—Tacrolimus—atopic dermatitis	0.000178	0.000622	CcSEcCtD
Vandetanib—Headache—Mometasone—atopic dermatitis	0.000177	0.000619	CcSEcCtD
Vandetanib—Arrhythmia—Hydrocortisone—atopic dermatitis	0.000176	0.000617	CcSEcCtD
Vandetanib—Nausea—Fluocinolone Acetonide—atopic dermatitis	0.000176	0.000615	CcSEcCtD
Vandetanib—Eye disorder—Methylprednisolone—atopic dermatitis	0.000173	0.000606	CcSEcCtD
Vandetanib—Mental disorder—Hydrocortisone—atopic dermatitis	0.000173	0.000605	CcSEcCtD
Vandetanib—VEGFA—Betamethasone—Hydrocortisone—atopic dermatitis	0.000172	0.0323	CbGdCrCtD
Vandetanib—VEGFA—Dexamethasone—Hydrocortisone—atopic dermatitis	0.000172	0.0323	CbGdCrCtD
Vandetanib—Cardiac disorder—Methylprednisolone—atopic dermatitis	0.000172	0.000602	CcSEcCtD
Vandetanib—Malnutrition—Hydrocortisone—atopic dermatitis	0.000172	0.000601	CcSEcCtD
Vandetanib—Bradycardia—Dexamethasone—atopic dermatitis	0.000172	0.000601	CcSEcCtD
Vandetanib—Bradycardia—Betamethasone—atopic dermatitis	0.000172	0.000601	CcSEcCtD
Vandetanib—Neutropenia—Prednisone—atopic dermatitis	0.000172	0.0006	CcSEcCtD
Vandetanib—Haemoglobin—Betamethasone—atopic dermatitis	0.00017	0.000593	CcSEcCtD
Vandetanib—Haemoglobin—Dexamethasone—atopic dermatitis	0.00017	0.000593	CcSEcCtD
Vandetanib—Haemorrhage—Dexamethasone—atopic dermatitis	0.000169	0.00059	CcSEcCtD
Vandetanib—Haemorrhage—Betamethasone—atopic dermatitis	0.000169	0.00059	CcSEcCtD
Vandetanib—Angiopathy—Methylprednisolone—atopic dermatitis	0.000168	0.000589	CcSEcCtD
Vandetanib—Nausea—Mometasone—atopic dermatitis	0.000168	0.000587	CcSEcCtD
Vandetanib—Mediastinal disorder—Methylprednisolone—atopic dermatitis	0.000167	0.000585	CcSEcCtD
Vandetanib—Arrhythmia—Triamcinolone—atopic dermatitis	0.000166	0.000581	CcSEcCtD
Vandetanib—Weight decreased—Prednisone—atopic dermatitis	0.000166	0.000581	CcSEcCtD
Vandetanib—Vision blurred—Prednisolone—atopic dermatitis	0.000166	0.00058	CcSEcCtD
Vandetanib—Arrhythmia—Methylprednisolone—atopic dermatitis	0.000166	0.00058	CcSEcCtD
Vandetanib—Hyperglycaemia—Prednisone—atopic dermatitis	0.000166	0.000579	CcSEcCtD
Vandetanib—Depression—Prednisone—atopic dermatitis	0.000163	0.000571	CcSEcCtD
Vandetanib—Visual impairment—Dexamethasone—atopic dermatitis	0.000163	0.000569	CcSEcCtD
Vandetanib—Visual impairment—Betamethasone—atopic dermatitis	0.000163	0.000569	CcSEcCtD
Vandetanib—Mental disorder—Methylprednisolone—atopic dermatitis	0.000163	0.000568	CcSEcCtD
Vandetanib—VEGFA—Betamethasone—Methylprednisolone—atopic dermatitis	0.000162	0.0305	CbGdCrCtD
Vandetanib—VEGFA—Dexamethasone—Methylprednisolone—atopic dermatitis	0.000162	0.0305	CbGdCrCtD
Vandetanib—Malnutrition—Methylprednisolone—atopic dermatitis	0.000161	0.000565	CcSEcCtD
Vandetanib—Asthenia—Tacrolimus—atopic dermatitis	0.000161	0.000564	CcSEcCtD
Vandetanib—VEGFA—Dexamethasone—Betamethasone—atopic dermatitis	0.00016	0.03	CbGdCrCtD
Vandetanib—VEGFA—Betamethasone—Dexamethasone—atopic dermatitis	0.00016	0.03	CbGdCrCtD
Vandetanib—Pruritus—Tacrolimus—atopic dermatitis	0.000159	0.000556	CcSEcCtD
Vandetanib—Dysgeusia—Triamcinolone—atopic dermatitis	0.000158	0.000554	CcSEcCtD
Vandetanib—Eye disorder—Dexamethasone—atopic dermatitis	0.000158	0.000551	CcSEcCtD
Vandetanib—Eye disorder—Betamethasone—atopic dermatitis	0.000158	0.000551	CcSEcCtD
Vandetanib—VEGFA—Dexamethasone—Triamcinolone—atopic dermatitis	0.000156	0.0293	CbGdCrCtD
Vandetanib—VEGFA—Betamethasone—Triamcinolone—atopic dermatitis	0.000156	0.0293	CbGdCrCtD
Vandetanib—Loss of consciousness—Prednisolone—atopic dermatitis	0.000155	0.000541	CcSEcCtD
Vandetanib—Diarrhoea—Tacrolimus—atopic dermatitis	0.000154	0.000538	CcSEcCtD
Vandetanib—Angiopathy—Dexamethasone—atopic dermatitis	0.000153	0.000535	CcSEcCtD
Vandetanib—Angiopathy—Betamethasone—atopic dermatitis	0.000153	0.000535	CcSEcCtD
Vandetanib—Convulsion—Prednisolone—atopic dermatitis	0.000152	0.000533	CcSEcCtD
Vandetanib—Hypertension—Prednisolone—atopic dermatitis	0.000152	0.000531	CcSEcCtD
Vandetanib—Loss of consciousness—Hydrocortisone—atopic dermatitis	0.000151	0.000528	CcSEcCtD
Vandetanib—Arrhythmia—Betamethasone—atopic dermatitis	0.000151	0.000527	CcSEcCtD
Vandetanib—Arrhythmia—Dexamethasone—atopic dermatitis	0.000151	0.000527	CcSEcCtD
Vandetanib—Bradycardia—Prednisone—atopic dermatitis	0.00015	0.000523	CcSEcCtD
Vandetanib—Alopecia—Dexamethasone—atopic dermatitis	0.000149	0.000521	CcSEcCtD
Vandetanib—Alopecia—Betamethasone—atopic dermatitis	0.000149	0.000521	CcSEcCtD
Vandetanib—Convulsion—Hydrocortisone—atopic dermatitis	0.000149	0.000521	CcSEcCtD
Vandetanib—Dizziness—Tacrolimus—atopic dermatitis	0.000149	0.00052	CcSEcCtD
Vandetanib—Hypertension—Hydrocortisone—atopic dermatitis	0.000148	0.000519	CcSEcCtD
Vandetanib—VEGFA—Dexamethasone—Prednisone—atopic dermatitis	0.000148	0.0278	CbGdCrCtD
Vandetanib—VEGFA—Betamethasone—Prednisone—atopic dermatitis	0.000148	0.0278	CbGdCrCtD
Vandetanib—Haemoglobin—Prednisone—atopic dermatitis	0.000148	0.000516	CcSEcCtD
Vandetanib—Haemorrhage—Prednisone—atopic dermatitis	0.000147	0.000514	CcSEcCtD
Vandetanib—Anxiety—Hydrocortisone—atopic dermatitis	0.000146	0.00051	CcSEcCtD
Vandetanib—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—atopic dermatitis	0.000145	0.000508	CcSEcCtD
Vandetanib—VEGFA—Betamethasone—Prednisolone—atopic dermatitis	0.000145	0.0271	CbGdCrCtD
Vandetanib—VEGFA—Dexamethasone—Prednisolone—atopic dermatitis	0.000145	0.0271	CbGdCrCtD
Vandetanib—Oedema—Prednisolone—atopic dermatitis	0.000144	0.000502	CcSEcCtD
Vandetanib—Vomiting—Tacrolimus—atopic dermatitis	0.000143	0.0005	CcSEcCtD
Vandetanib—Loss of consciousness—Triamcinolone—atopic dermatitis	0.000142	0.000497	CcSEcCtD
Vandetanib—Loss of consciousness—Methylprednisolone—atopic dermatitis	0.000142	0.000496	CcSEcCtD
Vandetanib—Rash—Tacrolimus—atopic dermatitis	0.000142	0.000496	CcSEcCtD
Vandetanib—Dermatitis—Tacrolimus—atopic dermatitis	0.000142	0.000495	CcSEcCtD
Vandetanib—Cough—Triamcinolone—atopic dermatitis	0.000141	0.000494	CcSEcCtD
Vandetanib—Headache—Tacrolimus—atopic dermatitis	0.000141	0.000493	CcSEcCtD
Vandetanib—Oedema—Hydrocortisone—atopic dermatitis	0.00014	0.000491	CcSEcCtD
Vandetanib—Convulsion—Triamcinolone—atopic dermatitis	0.00014	0.00049	CcSEcCtD
Vandetanib—Convulsion—Methylprednisolone—atopic dermatitis	0.00014	0.000489	CcSEcCtD
Vandetanib—Hypertension—Triamcinolone—atopic dermatitis	0.00014	0.000489	CcSEcCtD
Vandetanib—Hypertension—Methylprednisolone—atopic dermatitis	0.000139	0.000488	CcSEcCtD
Vandetanib—Infection—Hydrocortisone—atopic dermatitis	0.000139	0.000487	CcSEcCtD
Vandetanib—Nervous system disorder—Hydrocortisone—atopic dermatitis	0.000138	0.000481	CcSEcCtD
Vandetanib—Arthralgia—Methylprednisolone—atopic dermatitis	0.000137	0.000481	CcSEcCtD
Vandetanib—Eye disorder—Prednisone—atopic dermatitis	0.000137	0.00048	CcSEcCtD
Vandetanib—Anxiety—Methylprednisolone—atopic dermatitis	0.000137	0.000479	CcSEcCtD
Vandetanib—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—atopic dermatitis	0.000137	0.000477	CcSEcCtD
Vandetanib—Skin disorder—Hydrocortisone—atopic dermatitis	0.000136	0.000476	CcSEcCtD
Vandetanib—Dry mouth—Triamcinolone—atopic dermatitis	0.000135	0.000471	CcSEcCtD
Vandetanib—Nausea—Tacrolimus—atopic dermatitis	0.000134	0.000467	CcSEcCtD
Vandetanib—Angiopathy—Prednisone—atopic dermatitis	0.000133	0.000466	CcSEcCtD
Vandetanib—Oedema—Triamcinolone—atopic dermatitis	0.000132	0.000462	CcSEcCtD
Vandetanib—Arrhythmia—Prednisone—atopic dermatitis	0.000131	0.000459	CcSEcCtD
Vandetanib—Infection—Triamcinolone—atopic dermatitis	0.000131	0.000459	CcSEcCtD
Vandetanib—Infection—Methylprednisolone—atopic dermatitis	0.000131	0.000458	CcSEcCtD
Vandetanib—Insomnia—Prednisolone—atopic dermatitis	0.00013	0.000454	CcSEcCtD
Vandetanib—Alopecia—Prednisone—atopic dermatitis	0.00013	0.000454	CcSEcCtD
Vandetanib—Nervous system disorder—Methylprednisolone—atopic dermatitis	0.000129	0.000452	CcSEcCtD
Vandetanib—Loss of consciousness—Dexamethasone—atopic dermatitis	0.000129	0.000451	CcSEcCtD
Vandetanib—Loss of consciousness—Betamethasone—atopic dermatitis	0.000129	0.000451	CcSEcCtD
Vandetanib—Paraesthesia—Prednisolone—atopic dermatitis	0.000129	0.000451	CcSEcCtD
Vandetanib—Mental disorder—Prednisone—atopic dermatitis	0.000129	0.00045	CcSEcCtD
Vandetanib—Skin disorder—Methylprednisolone—atopic dermatitis	0.000128	0.000448	CcSEcCtD
Vandetanib—Malnutrition—Prednisone—atopic dermatitis	0.000128	0.000447	CcSEcCtD
Vandetanib—Musculoskeletal discomfort—Hydrocortisone—atopic dermatitis	0.000128	0.000447	CcSEcCtD
Vandetanib—Convulsion—Dexamethasone—atopic dermatitis	0.000127	0.000445	CcSEcCtD
Vandetanib—Convulsion—Betamethasone—atopic dermatitis	0.000127	0.000445	CcSEcCtD
Vandetanib—Insomnia—Hydrocortisone—atopic dermatitis	0.000127	0.000444	CcSEcCtD
Vandetanib—Hypertension—Dexamethasone—atopic dermatitis	0.000127	0.000443	CcSEcCtD
Vandetanib—Hypertension—Betamethasone—atopic dermatitis	0.000127	0.000443	CcSEcCtD
Vandetanib—Paraesthesia—Hydrocortisone—atopic dermatitis	0.000126	0.00044	CcSEcCtD
Vandetanib—Anxiety—Dexamethasone—atopic dermatitis	0.000125	0.000436	CcSEcCtD
Vandetanib—Anxiety—Betamethasone—atopic dermatitis	0.000125	0.000436	CcSEcCtD
Vandetanib—Dyspepsia—Hydrocortisone—atopic dermatitis	0.000123	0.000432	CcSEcCtD
Vandetanib—Pain—Prednisolone—atopic dermatitis	0.000123	0.00043	CcSEcCtD
Vandetanib—Decreased appetite—Hydrocortisone—atopic dermatitis	0.000122	0.000426	CcSEcCtD
Vandetanib—Gastrointestinal disorder—Hydrocortisone—atopic dermatitis	0.000121	0.000424	CcSEcCtD
Vandetanib—Fatigue—Hydrocortisone—atopic dermatitis	0.000121	0.000423	CcSEcCtD
Vandetanib—Vision blurred—Prednisone—atopic dermatitis	0.000121	0.000421	CcSEcCtD
Vandetanib—Musculoskeletal discomfort—Triamcinolone—atopic dermatitis	0.00012	0.000421	CcSEcCtD
Vandetanib—Musculoskeletal discomfort—Methylprednisolone—atopic dermatitis	0.00012	0.00042	CcSEcCtD
Vandetanib—Pain—Hydrocortisone—atopic dermatitis	0.00012	0.000419	CcSEcCtD
Vandetanib—Oedema—Betamethasone—atopic dermatitis	0.00012	0.000419	CcSEcCtD
Vandetanib—Oedema—Dexamethasone—atopic dermatitis	0.00012	0.000419	CcSEcCtD
Vandetanib—Insomnia—Triamcinolone—atopic dermatitis	0.000119	0.000418	CcSEcCtD
Vandetanib—Insomnia—Methylprednisolone—atopic dermatitis	0.000119	0.000417	CcSEcCtD
Vandetanib—Infection—Betamethasone—atopic dermatitis	0.000119	0.000416	CcSEcCtD
Vandetanib—Infection—Dexamethasone—atopic dermatitis	0.000119	0.000416	CcSEcCtD
Vandetanib—Paraesthesia—Triamcinolone—atopic dermatitis	0.000119	0.000415	CcSEcCtD
Vandetanib—Paraesthesia—Methylprednisolone—atopic dermatitis	0.000118	0.000414	CcSEcCtD
Vandetanib—Dyspnoea—Triamcinolone—atopic dermatitis	0.000118	0.000412	CcSEcCtD
Vandetanib—Nervous system disorder—Betamethasone—atopic dermatitis	0.000118	0.000411	CcSEcCtD
Vandetanib—Nervous system disorder—Dexamethasone—atopic dermatitis	0.000118	0.000411	CcSEcCtD
Vandetanib—Thrombocytopenia—Dexamethasone—atopic dermatitis	0.000117	0.00041	CcSEcCtD
Vandetanib—Thrombocytopenia—Betamethasone—atopic dermatitis	0.000117	0.00041	CcSEcCtD
Vandetanib—Dyspepsia—Triamcinolone—atopic dermatitis	0.000116	0.000407	CcSEcCtD
Vandetanib—Dyspepsia—Methylprednisolone—atopic dermatitis	0.000116	0.000406	CcSEcCtD
Vandetanib—Gastrointestinal pain—Hydrocortisone—atopic dermatitis	0.000115	0.000401	CcSEcCtD
Vandetanib—Fatigue—Triamcinolone—atopic dermatitis	0.000114	0.000398	CcSEcCtD
Vandetanib—Fatigue—Methylprednisolone—atopic dermatitis	0.000114	0.000397	CcSEcCtD
Vandetanib—Pain—Triamcinolone—atopic dermatitis	0.000113	0.000395	CcSEcCtD
Vandetanib—Loss of consciousness—Prednisone—atopic dermatitis	0.000112	0.000393	CcSEcCtD
Vandetanib—Abdominal pain—Hydrocortisone—atopic dermatitis	0.000111	0.000388	CcSEcCtD
Vandetanib—Body temperature increased—Hydrocortisone—atopic dermatitis	0.000111	0.000388	CcSEcCtD
Vandetanib—Convulsion—Prednisone—atopic dermatitis	0.000111	0.000387	CcSEcCtD
Vandetanib—Hypertension—Prednisone—atopic dermatitis	0.00011	0.000386	CcSEcCtD
Vandetanib—Musculoskeletal discomfort—Dexamethasone—atopic dermatitis	0.000109	0.000382	CcSEcCtD
Vandetanib—Musculoskeletal discomfort—Betamethasone—atopic dermatitis	0.000109	0.000382	CcSEcCtD
Vandetanib—Arthralgia—Prednisone—atopic dermatitis	0.000109	0.000381	CcSEcCtD
Vandetanib—Anxiety—Prednisone—atopic dermatitis	0.000109	0.000379	CcSEcCtD
Vandetanib—Insomnia—Dexamethasone—atopic dermatitis	0.000108	0.000379	CcSEcCtD
Vandetanib—Insomnia—Betamethasone—atopic dermatitis	0.000108	0.000379	CcSEcCtD
Vandetanib—Unspecified disorder of skin and subcutaneous tissue—Prednisone—atopic dermatitis	0.000108	0.000378	CcSEcCtD
Vandetanib—Gastrointestinal pain—Methylprednisolone—atopic dermatitis	0.000108	0.000377	CcSEcCtD
Vandetanib—Paraesthesia—Dexamethasone—atopic dermatitis	0.000108	0.000376	CcSEcCtD
Vandetanib—Paraesthesia—Betamethasone—atopic dermatitis	0.000108	0.000376	CcSEcCtD
Vandetanib—Dyspepsia—Betamethasone—atopic dermatitis	0.000106	0.000369	CcSEcCtD
Vandetanib—Dyspepsia—Dexamethasone—atopic dermatitis	0.000106	0.000369	CcSEcCtD
Vandetanib—Body temperature increased—Triamcinolone—atopic dermatitis	0.000104	0.000365	CcSEcCtD
Vandetanib—Oedema—Prednisone—atopic dermatitis	0.000104	0.000365	CcSEcCtD
Vandetanib—Abdominal pain—Methylprednisolone—atopic dermatitis	0.000104	0.000364	CcSEcCtD
Vandetanib—Decreased appetite—Betamethasone—atopic dermatitis	0.000104	0.000364	CcSEcCtD
Vandetanib—Decreased appetite—Dexamethasone—atopic dermatitis	0.000104	0.000364	CcSEcCtD
Vandetanib—Infection—Prednisone—atopic dermatitis	0.000104	0.000363	CcSEcCtD
Vandetanib—Gastrointestinal disorder—Betamethasone—atopic dermatitis	0.000103	0.000362	CcSEcCtD
Vandetanib—Gastrointestinal disorder—Dexamethasone—atopic dermatitis	0.000103	0.000362	CcSEcCtD
Vandetanib—Fatigue—Betamethasone—atopic dermatitis	0.000103	0.000361	CcSEcCtD
Vandetanib—Fatigue—Dexamethasone—atopic dermatitis	0.000103	0.000361	CcSEcCtD
Vandetanib—Pain—Dexamethasone—atopic dermatitis	0.000102	0.000358	CcSEcCtD
Vandetanib—Pain—Betamethasone—atopic dermatitis	0.000102	0.000358	CcSEcCtD
Vandetanib—Nervous system disorder—Prednisone—atopic dermatitis	0.000102	0.000358	CcSEcCtD
Vandetanib—Skin disorder—Prednisone—atopic dermatitis	0.000101	0.000355	CcSEcCtD
Vandetanib—Asthenia—Hydrocortisone—atopic dermatitis	0.000101	0.000352	CcSEcCtD
Vandetanib—Pruritus—Hydrocortisone—atopic dermatitis	9.93e-05	0.000347	CcSEcCtD
Vandetanib—Gastrointestinal pain—Betamethasone—atopic dermatitis	9.8e-05	0.000343	CcSEcCtD
Vandetanib—Gastrointestinal pain—Dexamethasone—atopic dermatitis	9.8e-05	0.000343	CcSEcCtD
Vandetanib—Diarrhoea—Hydrocortisone—atopic dermatitis	9.6e-05	0.000336	CcSEcCtD
Vandetanib—Musculoskeletal discomfort—Prednisone—atopic dermatitis	9.51e-05	0.000333	CcSEcCtD
Vandetanib—Dizziness—Prednisolone—atopic dermatitis	9.5e-05	0.000332	CcSEcCtD
Vandetanib—Asthenia—Triamcinolone—atopic dermatitis	9.48e-05	0.000331	CcSEcCtD
Vandetanib—Body temperature increased—Dexamethasone—atopic dermatitis	9.47e-05	0.000331	CcSEcCtD
Vandetanib—Abdominal pain—Dexamethasone—atopic dermatitis	9.47e-05	0.000331	CcSEcCtD
Vandetanib—Abdominal pain—Betamethasone—atopic dermatitis	9.47e-05	0.000331	CcSEcCtD
Vandetanib—Body temperature increased—Betamethasone—atopic dermatitis	9.47e-05	0.000331	CcSEcCtD
Vandetanib—Asthenia—Methylprednisolone—atopic dermatitis	9.46e-05	0.000331	CcSEcCtD
Vandetanib—Insomnia—Prednisone—atopic dermatitis	9.44e-05	0.00033	CcSEcCtD
Vandetanib—Paraesthesia—Prednisone—atopic dermatitis	9.37e-05	0.000328	CcSEcCtD
Vandetanib—Pruritus—Triamcinolone—atopic dermatitis	9.35e-05	0.000327	CcSEcCtD
Vandetanib—Pruritus—Methylprednisolone—atopic dermatitis	9.32e-05	0.000326	CcSEcCtD
Vandetanib—Dizziness—Hydrocortisone—atopic dermatitis	9.28e-05	0.000324	CcSEcCtD
Vandetanib—Dyspepsia—Prednisone—atopic dermatitis	9.19e-05	0.000321	CcSEcCtD
Vandetanib—Decreased appetite—Prednisone—atopic dermatitis	9.07e-05	0.000317	CcSEcCtD
Vandetanib—Rash—Prednisolone—atopic dermatitis	9.06e-05	0.000317	CcSEcCtD
Vandetanib—Dermatitis—Prednisolone—atopic dermatitis	9.05e-05	0.000316	CcSEcCtD
Vandetanib—Diarrhoea—Methylprednisolone—atopic dermatitis	9.02e-05	0.000315	CcSEcCtD
Vandetanib—Fatigue—Prednisone—atopic dermatitis	9e-05	0.000315	CcSEcCtD
Vandetanib—Headache—Prednisolone—atopic dermatitis	9e-05	0.000315	CcSEcCtD
Vandetanib—Constipation—Prednisone—atopic dermatitis	8.93e-05	0.000312	CcSEcCtD
Vandetanib—Vomiting—Hydrocortisone—atopic dermatitis	8.92e-05	0.000312	CcSEcCtD
Vandetanib—Rash—Hydrocortisone—atopic dermatitis	8.85e-05	0.000309	CcSEcCtD
Vandetanib—Dermatitis—Hydrocortisone—atopic dermatitis	8.84e-05	0.000309	CcSEcCtD
Vandetanib—Headache—Hydrocortisone—atopic dermatitis	8.79e-05	0.000307	CcSEcCtD
Vandetanib—Dizziness—Triamcinolone—atopic dermatitis	8.74e-05	0.000305	CcSEcCtD
Vandetanib—Dizziness—Methylprednisolone—atopic dermatitis	8.72e-05	0.000305	CcSEcCtD
Vandetanib—Asthenia—Dexamethasone—atopic dermatitis	8.6e-05	0.000301	CcSEcCtD
Vandetanib—Asthenia—Betamethasone—atopic dermatitis	8.6e-05	0.000301	CcSEcCtD
Vandetanib—Gastrointestinal pain—Prednisone—atopic dermatitis	8.54e-05	0.000298	CcSEcCtD
Vandetanib—Nausea—Prednisolone—atopic dermatitis	8.53e-05	0.000298	CcSEcCtD
Vandetanib—Pruritus—Dexamethasone—atopic dermatitis	8.48e-05	0.000297	CcSEcCtD
Vandetanib—Pruritus—Betamethasone—atopic dermatitis	8.48e-05	0.000297	CcSEcCtD
Vandetanib—Vomiting—Triamcinolone—atopic dermatitis	8.4e-05	0.000294	CcSEcCtD
Vandetanib—Vomiting—Methylprednisolone—atopic dermatitis	8.38e-05	0.000293	CcSEcCtD
Vandetanib—Nausea—Hydrocortisone—atopic dermatitis	8.33e-05	0.000291	CcSEcCtD
Vandetanib—Rash—Triamcinolone—atopic dermatitis	8.33e-05	0.000291	CcSEcCtD
Vandetanib—Dermatitis—Triamcinolone—atopic dermatitis	8.32e-05	0.000291	CcSEcCtD
Vandetanib—Rash—Methylprednisolone—atopic dermatitis	8.31e-05	0.000291	CcSEcCtD
Vandetanib—Dermatitis—Methylprednisolone—atopic dermatitis	8.3e-05	0.00029	CcSEcCtD
Vandetanib—Headache—Triamcinolone—atopic dermatitis	8.28e-05	0.000289	CcSEcCtD
Vandetanib—Headache—Methylprednisolone—atopic dermatitis	8.26e-05	0.000289	CcSEcCtD
Vandetanib—Abdominal pain—Prednisone—atopic dermatitis	8.25e-05	0.000289	CcSEcCtD
Vandetanib—Body temperature increased—Prednisone—atopic dermatitis	8.25e-05	0.000289	CcSEcCtD
Vandetanib—Diarrhoea—Betamethasone—atopic dermatitis	8.2e-05	0.000287	CcSEcCtD
Vandetanib—Diarrhoea—Dexamethasone—atopic dermatitis	8.2e-05	0.000287	CcSEcCtD
Vandetanib—Dizziness—Dexamethasone—atopic dermatitis	7.93e-05	0.000277	CcSEcCtD
Vandetanib—Dizziness—Betamethasone—atopic dermatitis	7.93e-05	0.000277	CcSEcCtD
Vandetanib—Nausea—Triamcinolone—atopic dermatitis	7.85e-05	0.000274	CcSEcCtD
Vandetanib—Nausea—Methylprednisolone—atopic dermatitis	7.83e-05	0.000274	CcSEcCtD
Vandetanib—Vomiting—Dexamethasone—atopic dermatitis	7.62e-05	0.000266	CcSEcCtD
Vandetanib—Vomiting—Betamethasone—atopic dermatitis	7.62e-05	0.000266	CcSEcCtD
Vandetanib—Rash—Dexamethasone—atopic dermatitis	7.56e-05	0.000264	CcSEcCtD
Vandetanib—Rash—Betamethasone—atopic dermatitis	7.56e-05	0.000264	CcSEcCtD
Vandetanib—Dermatitis—Dexamethasone—atopic dermatitis	7.55e-05	0.000264	CcSEcCtD
Vandetanib—Dermatitis—Betamethasone—atopic dermatitis	7.55e-05	0.000264	CcSEcCtD
Vandetanib—Headache—Dexamethasone—atopic dermatitis	7.51e-05	0.000263	CcSEcCtD
Vandetanib—Headache—Betamethasone—atopic dermatitis	7.51e-05	0.000263	CcSEcCtD
Vandetanib—Asthenia—Prednisone—atopic dermatitis	7.49e-05	0.000262	CcSEcCtD
Vandetanib—Pruritus—Prednisone—atopic dermatitis	7.38e-05	0.000258	CcSEcCtD
Vandetanib—Diarrhoea—Prednisone—atopic dermatitis	7.14e-05	0.00025	CcSEcCtD
Vandetanib—Nausea—Betamethasone—atopic dermatitis	7.12e-05	0.000249	CcSEcCtD
Vandetanib—Nausea—Dexamethasone—atopic dermatitis	7.12e-05	0.000249	CcSEcCtD
Vandetanib—Dizziness—Prednisone—atopic dermatitis	6.9e-05	0.000241	CcSEcCtD
Vandetanib—Vomiting—Prednisone—atopic dermatitis	6.64e-05	0.000232	CcSEcCtD
Vandetanib—Rash—Prednisone—atopic dermatitis	6.58e-05	0.00023	CcSEcCtD
Vandetanib—Dermatitis—Prednisone—atopic dermatitis	6.58e-05	0.00023	CcSEcCtD
Vandetanib—Headache—Prednisone—atopic dermatitis	6.54e-05	0.000229	CcSEcCtD
Vandetanib—Nausea—Prednisone—atopic dermatitis	6.2e-05	0.000217	CcSEcCtD
Vandetanib—LCK—Immune System—IL18—atopic dermatitis	1.56e-05	6.96e-05	CbGpPWpGaD
Vandetanib—FYN—Disease—CCR5—atopic dermatitis	1.56e-05	6.95e-05	CbGpPWpGaD
Vandetanib—ABL1—Innate Immune System—MAPK8—atopic dermatitis	1.56e-05	6.95e-05	CbGpPWpGaD
Vandetanib—LCK—Hemostasis—IL2—atopic dermatitis	1.55e-05	6.91e-05	CbGpPWpGaD
Vandetanib—FYN—Innate Immune System—MAPK8—atopic dermatitis	1.54e-05	6.88e-05	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—CCR5—atopic dermatitis	1.54e-05	6.87e-05	CbGpPWpGaD
Vandetanib—LCK—Immune System—CD8A—atopic dermatitis	1.54e-05	6.85e-05	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—TAC1—atopic dermatitis	1.54e-05	6.84e-05	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—NPS—atopic dermatitis	1.54e-05	6.84e-05	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—NGF—atopic dermatitis	1.53e-05	6.82e-05	CbGpPWpGaD
Vandetanib—ERBB3—Innate Immune System—IL6—atopic dermatitis	1.53e-05	6.81e-05	CbGpPWpGaD
Vandetanib—BLK—Immune System—MAPK8—atopic dermatitis	1.52e-05	6.78e-05	CbGpPWpGaD
Vandetanib—MKNK1—Signaling Pathways—MAPK8—atopic dermatitis	1.52e-05	6.78e-05	CbGpPWpGaD
Vandetanib—ERBB3—Immune System—IL1B—atopic dermatitis	1.52e-05	6.78e-05	CbGpPWpGaD
Vandetanib—ERBB3—Disease—CD4—atopic dermatitis	1.52e-05	6.78e-05	CbGpPWpGaD
Vandetanib—YES1—Developmental Biology—IL6—atopic dermatitis	1.52e-05	6.77e-05	CbGpPWpGaD
Vandetanib—LCK—Innate Immune System—CD4—atopic dermatitis	1.52e-05	6.76e-05	CbGpPWpGaD
Vandetanib—FGR—Immune System—MAPK8—atopic dermatitis	1.52e-05	6.76e-05	CbGpPWpGaD
Vandetanib—ERBB3—Immune System—IL2—atopic dermatitis	1.52e-05	6.75e-05	CbGpPWpGaD
Vandetanib—EGFR—Adaptive Immune System—CD4—atopic dermatitis	1.51e-05	6.74e-05	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—CXCR3—atopic dermatitis	1.51e-05	6.71e-05	CbGpPWpGaD
Vandetanib—YES1—Immune System—IFNG—atopic dermatitis	1.5e-05	6.67e-05	CbGpPWpGaD
Vandetanib—EGFR—Signaling by NGF—IL6—atopic dermatitis	1.49e-05	6.65e-05	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling Pathways—NFKBIA—atopic dermatitis	1.49e-05	6.65e-05	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—CCR5—atopic dermatitis	1.49e-05	6.63e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Immune System—NFKBIA—atopic dermatitis	1.49e-05	6.62e-05	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—NPS—atopic dermatitis	1.48e-05	6.59e-05	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—TAC1—atopic dermatitis	1.48e-05	6.59e-05	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—CCR3—atopic dermatitis	1.47e-05	6.55e-05	CbGpPWpGaD
Vandetanib—LCK—Cytokine Signaling in Immune system—IL6—atopic dermatitis	1.46e-05	6.52e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—CXCL10—atopic dermatitis	1.46e-05	6.51e-05	CbGpPWpGaD
Vandetanib—LCK—Adaptive Immune System—CD4—atopic dermatitis	1.46e-05	6.49e-05	CbGpPWpGaD
Vandetanib—LYN—Immune System—NFKBIA—atopic dermatitis	1.46e-05	6.48e-05	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—NFKBIA—atopic dermatitis	1.45e-05	6.48e-05	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—CXCR3—atopic dermatitis	1.45e-05	6.47e-05	CbGpPWpGaD
Vandetanib—ABL1—Immune System—NFKBIA—atopic dermatitis	1.45e-05	6.45e-05	CbGpPWpGaD
Vandetanib—YES1—Immune System—CD4—atopic dermatitis	1.45e-05	6.44e-05	CbGpPWpGaD
Vandetanib—LCK—Signaling by NGF—IL6—atopic dermatitis	1.44e-05	6.41e-05	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—NFKBIA—atopic dermatitis	1.44e-05	6.41e-05	CbGpPWpGaD
Vandetanib—FYN—Immune System—NFKBIA—atopic dermatitis	1.43e-05	6.38e-05	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—CXCL10—atopic dermatitis	1.43e-05	6.38e-05	CbGpPWpGaD
Vandetanib—ABCC1—Disease—CCR5—atopic dermatitis	1.43e-05	6.37e-05	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—IL5—atopic dermatitis	1.43e-05	6.36e-05	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—CXCL10—atopic dermatitis	1.41e-05	6.28e-05	CbGpPWpGaD
Vandetanib—LYN—Developmental Biology—TNF—atopic dermatitis	1.41e-05	6.26e-05	CbGpPWpGaD
Vandetanib—AXL—Signaling Pathways—IL6—atopic dermatitis	1.4e-05	6.25e-05	CbGpPWpGaD
Vandetanib—ALB—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	1.4e-05	6.24e-05	CbGpPWpGaD
Vandetanib—ABL1—Developmental Biology—TNF—atopic dermatitis	1.4e-05	6.23e-05	CbGpPWpGaD
Vandetanib—ERBB3—Immune System—MAPK8—atopic dermatitis	1.4e-05	6.21e-05	CbGpPWpGaD
Vandetanib—MKNK1—Disease—IL6—atopic dermatitis	1.39e-05	6.18e-05	CbGpPWpGaD
Vandetanib—FYN—Developmental Biology—TNF—atopic dermatitis	1.38e-05	6.16e-05	CbGpPWpGaD
Vandetanib—SRC—Immune System—IL18—atopic dermatitis	1.38e-05	6.16e-05	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—IL5—atopic dermatitis	1.38e-05	6.13e-05	CbGpPWpGaD
Vandetanib—SRC—Hemostasis—IL2—atopic dermatitis	1.37e-05	6.12e-05	CbGpPWpGaD
Vandetanib—SRC—Immune System—CD8A—atopic dermatitis	1.36e-05	6.07e-05	CbGpPWpGaD
Vandetanib—EGFR—Axon guidance—IL6—atopic dermatitis	1.35e-05	6.02e-05	CbGpPWpGaD
Vandetanib—EGFR—Disease—CCR5—atopic dermatitis	1.35e-05	6.01e-05	CbGpPWpGaD
Vandetanib—SRC—Innate Immune System—CD4—atopic dermatitis	1.34e-05	5.98e-05	CbGpPWpGaD
Vandetanib—YES1—Innate Immune System—IL6—atopic dermatitis	1.34e-05	5.98e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Immune System—CASP8—atopic dermatitis	1.34e-05	5.97e-05	CbGpPWpGaD
Vandetanib—YES1—Immune System—IL1B—atopic dermatitis	1.34e-05	5.95e-05	CbGpPWpGaD
Vandetanib—EGFR—Innate Immune System—MAPK8—atopic dermatitis	1.33e-05	5.94e-05	CbGpPWpGaD
Vandetanib—ALB—Transmembrane transport of small molecules—PPARA—atopic dermatitis	1.33e-05	5.93e-05	CbGpPWpGaD
Vandetanib—YES1—Immune System—IL2—atopic dermatitis	1.33e-05	5.93e-05	CbGpPWpGaD
Vandetanib—LYN—Immune System—CASP8—atopic dermatitis	1.31e-05	5.85e-05	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—NPS—atopic dermatitis	1.31e-05	5.84e-05	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—TAC1—atopic dermatitis	1.31e-05	5.84e-05	CbGpPWpGaD
Vandetanib—ABL1—Immune System—CASP8—atopic dermatitis	1.31e-05	5.82e-05	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—NFKBIA—atopic dermatitis	1.31e-05	5.82e-05	CbGpPWpGaD
Vandetanib—LCK—Disease—CCR5—atopic dermatitis	1.3e-05	5.79e-05	CbGpPWpGaD
Vandetanib—FYN—Immune System—CASP8—atopic dermatitis	1.29e-05	5.76e-05	CbGpPWpGaD
Vandetanib—SRC—Adaptive Immune System—CD4—atopic dermatitis	1.29e-05	5.75e-05	CbGpPWpGaD
Vandetanib—LCK—Innate Immune System—MAPK8—atopic dermatitis	1.29e-05	5.72e-05	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—CXCR3—atopic dermatitis	1.29e-05	5.72e-05	CbGpPWpGaD
Vandetanib—BMPR1B—Signaling Pathways—IL6—atopic dermatitis	1.28e-05	5.71e-05	CbGpPWpGaD
Vandetanib—SRC—Signaling by NGF—IL6—atopic dermatitis	1.27e-05	5.67e-05	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—NFKBIA—atopic dermatitis	1.26e-05	5.62e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—CCL5—atopic dermatitis	1.26e-05	5.61e-05	CbGpPWpGaD
Vandetanib—EGFR—Immune System—NFKBIA—atopic dermatitis	1.24e-05	5.52e-05	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—CCL5—atopic dermatitis	1.23e-05	5.49e-05	CbGpPWpGaD
Vandetanib—YES1—Immune System—MAPK8—atopic dermatitis	1.23e-05	5.46e-05	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—IL5—atopic dermatitis	1.22e-05	5.43e-05	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—CXCL10—atopic dermatitis	1.22e-05	5.42e-05	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—CCL5—atopic dermatitis	1.21e-05	5.4e-05	CbGpPWpGaD
Vandetanib—EGFR—Developmental Biology—TNF—atopic dermatitis	1.2e-05	5.32e-05	CbGpPWpGaD
Vandetanib—LCK—Immune System—NFKBIA—atopic dermatitis	1.19e-05	5.31e-05	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—CXCL10—atopic dermatitis	1.17e-05	5.23e-05	CbGpPWpGaD
Vandetanib—FLT4—Signaling Pathways—IL6—atopic dermatitis	1.17e-05	5.23e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—NGF—atopic dermatitis	1.17e-05	5.19e-05	CbGpPWpGaD
Vandetanib—RIPK2—Signaling Pathways—CXCL8—atopic dermatitis	1.16e-05	5.18e-05	CbGpPWpGaD
Vandetanib—SRC—Axon guidance—IL6—atopic dermatitis	1.15e-05	5.13e-05	CbGpPWpGaD
Vandetanib—SRC—Disease—CCR5—atopic dermatitis	1.15e-05	5.12e-05	CbGpPWpGaD
Vandetanib—ABCC1—Metabolism—PPARA—atopic dermatitis	1.15e-05	5.12e-05	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—NGF—atopic dermatitis	1.14e-05	5.08e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Immune System—IFNG—atopic dermatitis	1.14e-05	5.08e-05	CbGpPWpGaD
Vandetanib—SRC—Innate Immune System—MAPK8—atopic dermatitis	1.14e-05	5.07e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—CCR5—atopic dermatitis	1.13e-05	5.05e-05	CbGpPWpGaD
Vandetanib—LYN—Developmental Biology—IL6—atopic dermatitis	1.13e-05	5.05e-05	CbGpPWpGaD
Vandetanib—ABL1—Developmental Biology—IL6—atopic dermatitis	1.13e-05	5.03e-05	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—NGF—atopic dermatitis	1.12e-05	5e-05	CbGpPWpGaD
Vandetanib—IRAK4—Immune System—IL6—atopic dermatitis	1.12e-05	4.98e-05	CbGpPWpGaD
Vandetanib—EGFR—Immune System—CASP8—atopic dermatitis	1.12e-05	4.97e-05	CbGpPWpGaD
Vandetanib—LYN—Immune System—IFNG—atopic dermatitis	1.12e-05	4.97e-05	CbGpPWpGaD
Vandetanib—FYN—Developmental Biology—IL6—atopic dermatitis	1.12e-05	4.97e-05	CbGpPWpGaD
Vandetanib—RIPK2—Signaling Pathways—IL2—atopic dermatitis	1.11e-05	4.95e-05	CbGpPWpGaD
Vandetanib—ABL1—Immune System—IFNG—atopic dermatitis	1.11e-05	4.95e-05	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—CCR5—atopic dermatitis	1.11e-05	4.95e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Immune System—CD4—atopic dermatitis	1.1e-05	4.91e-05	CbGpPWpGaD
Vandetanib—FYN—Immune System—IFNG—atopic dermatitis	1.1e-05	4.9e-05	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—CCR5—atopic dermatitis	1.09e-05	4.87e-05	CbGpPWpGaD
Vandetanib—LYN—Immune System—CD4—atopic dermatitis	1.08e-05	4.8e-05	CbGpPWpGaD
Vandetanib—LCK—Immune System—CASP8—atopic dermatitis	1.08e-05	4.79e-05	CbGpPWpGaD
Vandetanib—ABL1—Immune System—CD4—atopic dermatitis	1.07e-05	4.78e-05	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling Pathways—CXCL8—atopic dermatitis	1.06e-05	4.74e-05	CbGpPWpGaD
Vandetanib—FYN—Immune System—CD4—atopic dermatitis	1.06e-05	4.73e-05	CbGpPWpGaD
Vandetanib—SRC—Immune System—NFKBIA—atopic dermatitis	1.06e-05	4.71e-05	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—CCL5—atopic dermatitis	1.05e-05	4.67e-05	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—CXCL10—atopic dermatitis	1.04e-05	4.63e-05	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—GLB1—atopic dermatitis	1.04e-05	4.62e-05	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—CXCL8—atopic dermatitis	1.04e-05	4.62e-05	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—CXCL8—atopic dermatitis	1.03e-05	4.57e-05	CbGpPWpGaD
Vandetanib—RIPK2—Signaling Pathways—MAPK8—atopic dermatitis	1.02e-05	4.56e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Innate Immune System—IL6—atopic dermatitis	1.02e-05	4.56e-05	CbGpPWpGaD
Vandetanib—SRC—Developmental Biology—TNF—atopic dermatitis	1.02e-05	4.54e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Immune System—IL1B—atopic dermatitis	1.02e-05	4.53e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Disease—CD4—atopic dermatitis	1.02e-05	4.53e-05	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling Pathways—IL2—atopic dermatitis	1.02e-05	4.53e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Immune System—IL2—atopic dermatitis	1.01e-05	4.51e-05	CbGpPWpGaD
Vandetanib—ABCG2—Metabolism—PPARA—atopic dermatitis	1.01e-05	4.5e-05	CbGpPWpGaD
Vandetanib—RIPK2—Immune System—IL6—atopic dermatitis	1.01e-05	4.5e-05	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—CCL5—atopic dermatitis	1.01e-05	4.5e-05	CbGpPWpGaD
Vandetanib—LYN—Innate Immune System—IL6—atopic dermatitis	1e-05	4.46e-05	CbGpPWpGaD
Vandetanib—ABL1—Innate Immune System—IL6—atopic dermatitis	9.97e-06	4.44e-05	CbGpPWpGaD
Vandetanib—LYN—Immune System—IL1B—atopic dermatitis	9.97e-06	4.44e-05	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—ADSL—atopic dermatitis	9.95e-06	4.43e-05	CbGpPWpGaD
Vandetanib—LYN—Immune System—IL2—atopic dermatitis	9.93e-06	4.42e-05	CbGpPWpGaD
Vandetanib—ABL1—Immune System—IL1B—atopic dermatitis	9.92e-06	4.42e-05	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—IL2—atopic dermatitis	9.92e-06	4.41e-05	CbGpPWpGaD
Vandetanib—ABL1—Immune System—IL2—atopic dermatitis	9.88e-06	4.4e-05	CbGpPWpGaD
Vandetanib—FYN—Innate Immune System—IL6—atopic dermatitis	9.86e-06	4.39e-05	CbGpPWpGaD
Vandetanib—FYN—Immune System—IL1B—atopic dermatitis	9.81e-06	4.37e-05	CbGpPWpGaD
Vandetanib—FYN—Disease—CD4—atopic dermatitis	9.81e-06	4.37e-05	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—IL2—atopic dermatitis	9.81e-06	4.37e-05	CbGpPWpGaD
Vandetanib—FYN—Immune System—IL2—atopic dermatitis	9.77e-06	4.35e-05	CbGpPWpGaD
Vandetanib—BLK—Immune System—IL6—atopic dermatitis	9.73e-06	4.33e-05	CbGpPWpGaD
Vandetanib—MKNK1—Signaling Pathways—IL6—atopic dermatitis	9.73e-06	4.33e-05	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—NGF—atopic dermatitis	9.71e-06	4.32e-05	CbGpPWpGaD
Vandetanib—FGR—Immune System—IL6—atopic dermatitis	9.7e-06	4.32e-05	CbGpPWpGaD
Vandetanib—EGFR—Signaling by GPCR—CXCL8—atopic dermatitis	9.67e-06	4.3e-05	CbGpPWpGaD
Vandetanib—EGFR—Developmental Biology—IL6—atopic dermatitis	9.65e-06	4.3e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—NFKBIA—atopic dermatitis	9.62e-06	4.28e-05	CbGpPWpGaD
Vandetanib—SRC—Immune System—CASP8—atopic dermatitis	9.54e-06	4.24e-05	CbGpPWpGaD
Vandetanib—EGFR—Immune System—IFNG—atopic dermatitis	9.5e-06	4.23e-05	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—CCR5—atopic dermatitis	9.45e-06	4.21e-05	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—NFKBIA—atopic dermatitis	9.42e-06	4.19e-05	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling Pathways—MAPK8—atopic dermatitis	9.37e-06	4.17e-05	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—NGF—atopic dermatitis	9.36e-06	4.17e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Immune System—MAPK8—atopic dermatitis	9.33e-06	4.15e-05	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—CXCL8—atopic dermatitis	9.33e-06	4.15e-05	CbGpPWpGaD
Vandetanib—ALB—Hemostasis—IL2—atopic dermatitis	9.28e-06	4.13e-05	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—NFKBIA—atopic dermatitis	9.27e-06	4.13e-05	CbGpPWpGaD
Vandetanib—EGFR—Signaling by GPCR—IL2—atopic dermatitis	9.24e-06	4.11e-05	CbGpPWpGaD
Vandetanib—EGFR—Immune System—CD4—atopic dermatitis	9.18e-06	4.09e-05	CbGpPWpGaD
Vandetanib—LCK—Immune System—IFNG—atopic dermatitis	9.16e-06	4.08e-05	CbGpPWpGaD
Vandetanib—LYN—Immune System—MAPK8—atopic dermatitis	9.14e-06	4.07e-05	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—MAPK8—atopic dermatitis	9.13e-06	4.06e-05	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—CCR5—atopic dermatitis	9.11e-06	4.05e-05	CbGpPWpGaD
Vandetanib—ABL1—Immune System—MAPK8—atopic dermatitis	9.1e-06	4.05e-05	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—MAPK8—atopic dermatitis	9.03e-06	4.02e-05	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—CXCL8—atopic dermatitis	9.01e-06	4.01e-05	CbGpPWpGaD
Vandetanib—FYN—Immune System—MAPK8—atopic dermatitis	9e-06	4e-05	CbGpPWpGaD
Vandetanib—ABCC1—Disease—CD4—atopic dermatitis	8.99e-06	4e-05	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—CCL5—atopic dermatitis	8.95e-06	3.98e-05	CbGpPWpGaD
Vandetanib—ERBB3—Immune System—IL6—atopic dermatitis	8.92e-06	3.97e-05	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—IL2—atopic dermatitis	8.91e-06	3.97e-05	CbGpPWpGaD
Vandetanib—LCK—Immune System—CD4—atopic dermatitis	8.85e-06	3.94e-05	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—IL2—atopic dermatitis	8.61e-06	3.83e-05	CbGpPWpGaD
Vandetanib—EGFR—Innate Immune System—IL6—atopic dermatitis	8.52e-06	3.79e-05	CbGpPWpGaD
Vandetanib—EGFR—Immune System—IL1B—atopic dermatitis	8.48e-06	3.77e-05	CbGpPWpGaD
Vandetanib—EGFR—Disease—CD4—atopic dermatitis	8.47e-06	3.77e-05	CbGpPWpGaD
Vandetanib—EGFR—Immune System—IL2—atopic dermatitis	8.44e-06	3.76e-05	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—NGF—atopic dermatitis	8.29e-06	3.69e-05	CbGpPWpGaD
Vandetanib—SRC—Developmental Biology—IL6—atopic dermatitis	8.23e-06	3.66e-05	CbGpPWpGaD
Vandetanib—ERBB3—Disease—IL6—atopic dermatitis	8.23e-06	3.66e-05	CbGpPWpGaD
Vandetanib—LCK—Innate Immune System—IL6—atopic dermatitis	8.21e-06	3.66e-05	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—MAPK8—atopic dermatitis	8.2e-06	3.65e-05	CbGpPWpGaD
Vandetanib—LCK—Immune System—IL1B—atopic dermatitis	8.17e-06	3.64e-05	CbGpPWpGaD
Vandetanib—LCK—Disease—CD4—atopic dermatitis	8.17e-06	3.63e-05	CbGpPWpGaD
Vandetanib—LCK—Immune System—IL2—atopic dermatitis	8.14e-06	3.62e-05	CbGpPWpGaD
Vandetanib—SRC—Immune System—IFNG—atopic dermatitis	8.11e-06	3.61e-05	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—CCR5—atopic dermatitis	8.06e-06	3.59e-05	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—NFKBIA—atopic dermatitis	8.01e-06	3.57e-05	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—MAPK8—atopic dermatitis	7.92e-06	3.53e-05	CbGpPWpGaD
Vandetanib—SRC—Immune System—CD4—atopic dermatitis	7.83e-06	3.49e-05	CbGpPWpGaD
Vandetanib—YES1—Immune System—IL6—atopic dermatitis	7.83e-06	3.48e-05	CbGpPWpGaD
Vandetanib—EGFR—Immune System—MAPK8—atopic dermatitis	7.77e-06	3.46e-05	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—NFKBIA—atopic dermatitis	7.72e-06	3.44e-05	CbGpPWpGaD
Vandetanib—LCK—Immune System—MAPK8—atopic dermatitis	7.49e-06	3.33e-05	CbGpPWpGaD
Vandetanib—SRC—Innate Immune System—IL6—atopic dermatitis	7.27e-06	3.24e-05	CbGpPWpGaD
Vandetanib—SRC—Immune System—IL1B—atopic dermatitis	7.23e-06	3.22e-05	CbGpPWpGaD
Vandetanib—SRC—Disease—CD4—atopic dermatitis	7.23e-06	3.22e-05	CbGpPWpGaD
Vandetanib—SRC—Immune System—IL2—atopic dermatitis	7.2e-06	3.21e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—CXCL8—atopic dermatitis	6.86e-06	3.05e-05	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—NFKBIA—atopic dermatitis	6.83e-06	3.04e-05	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—CXCL8—atopic dermatitis	6.72e-06	2.99e-05	CbGpPWpGaD
Vandetanib—SRC—Immune System—MAPK8—atopic dermatitis	6.63e-06	2.95e-05	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—CXCL8—atopic dermatitis	6.61e-06	2.94e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—IL2—atopic dermatitis	6.56e-06	2.92e-05	CbGpPWpGaD
Vandetanib—RIPK2—Signaling Pathways—IL6—atopic dermatitis	6.54e-06	2.91e-05	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—IL2—atopic dermatitis	6.42e-06	2.86e-05	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—IL2—atopic dermatitis	6.32e-06	2.81e-05	CbGpPWpGaD
Vandetanib—ALB—Metabolism—PPARA—atopic dermatitis	6.24e-06	2.78e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—MAPK8—atopic dermatitis	6.03e-06	2.69e-05	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling Pathways—IL6—atopic dermatitis	5.98e-06	2.66e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Immune System—IL6—atopic dermatitis	5.96e-06	2.65e-05	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—MAPK8—atopic dermatitis	5.91e-06	2.63e-05	CbGpPWpGaD
Vandetanib—LYN—Immune System—IL6—atopic dermatitis	5.84e-06	2.6e-05	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—IL6—atopic dermatitis	5.83e-06	2.59e-05	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—MAPK8—atopic dermatitis	5.82e-06	2.59e-05	CbGpPWpGaD
Vandetanib—ABL1—Immune System—IL6—atopic dermatitis	5.81e-06	2.59e-05	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—IL6—atopic dermatitis	5.76e-06	2.57e-05	CbGpPWpGaD
Vandetanib—FYN—Immune System—IL6—atopic dermatitis	5.75e-06	2.56e-05	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—CXCL8—atopic dermatitis	5.71e-06	2.54e-05	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—CXCL8—atopic dermatitis	5.51e-06	2.45e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Disease—IL6—atopic dermatitis	5.5e-06	2.45e-05	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—IL2—atopic dermatitis	5.46e-06	2.43e-05	CbGpPWpGaD
Vandetanib—EGFR—Signaling by GPCR—IL6—atopic dermatitis	5.43e-06	2.42e-05	CbGpPWpGaD
Vandetanib—FYN—Disease—IL6—atopic dermatitis	5.3e-06	2.36e-05	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—IL2—atopic dermatitis	5.26e-06	2.34e-05	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—IL6—atopic dermatitis	5.24e-06	2.33e-05	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—IL6—atopic dermatitis	5.06e-06	2.25e-05	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—MAPK8—atopic dermatitis	5.03e-06	2.24e-05	CbGpPWpGaD
Vandetanib—EGFR—Immune System—IL6—atopic dermatitis	4.96e-06	2.21e-05	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—CXCL8—atopic dermatitis	4.87e-06	2.17e-05	CbGpPWpGaD
Vandetanib—ABCC1—Disease—IL6—atopic dermatitis	4.86e-06	2.16e-05	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—MAPK8—atopic dermatitis	4.84e-06	2.16e-05	CbGpPWpGaD
Vandetanib—LCK—Immune System—IL6—atopic dermatitis	4.78e-06	2.13e-05	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—IL2—atopic dermatitis	4.66e-06	2.07e-05	CbGpPWpGaD
Vandetanib—EGFR—Disease—IL6—atopic dermatitis	4.58e-06	2.04e-05	CbGpPWpGaD
Vandetanib—LCK—Disease—IL6—atopic dermatitis	4.42e-06	1.97e-05	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—MAPK8—atopic dermatitis	4.29e-06	1.91e-05	CbGpPWpGaD
Vandetanib—SRC—Immune System—IL6—atopic dermatitis	4.23e-06	1.88e-05	CbGpPWpGaD
Vandetanib—SRC—Disease—IL6—atopic dermatitis	3.91e-06	1.74e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—IL6—atopic dermatitis	3.85e-06	1.72e-05	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—IL6—atopic dermatitis	3.77e-06	1.68e-05	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—IL6—atopic dermatitis	3.71e-06	1.65e-05	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—PPARA—atopic dermatitis	3.37e-06	1.5e-05	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—IL6—atopic dermatitis	3.21e-06	1.43e-05	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—IL6—atopic dermatitis	3.09e-06	1.38e-05	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—IL6—atopic dermatitis	2.74e-06	1.22e-05	CbGpPWpGaD
